Response to Carboplatin and Paclitaxel in the treatment of hereditary breast ovarian cancer syndrome (HBOC): a case report

被引：0
|
作者：
Mehmood, Faisal [1 ]
Touseef, Mumtaz [2 ]
Ashraf, Amna [2 ]
Rai, Izza Ali [3 ]
机构：
[1] Combined Mil Hosp, Dept Radiol, Lahore, Pakistan
[2] Combined Mil Hosp, Dept Med, Lahore, Pakistan
[3] Combined Mil Hosp, Dept Vasc Surg, Lahore, Pakistan
来源：
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2024年 / 74卷 / 12期
关键词：
Hereditary breast ovarian cancer; Breast cancer; Ovarian cancer; HBOC; BRCA; PALB2; Chemotherapy; Carboplatin; Paclitaxel; PREVALENCE; MUTATIONS;
D O I：
10.47391/JPMA.20059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The co-occurrence of primary breast cancer and primary ovarian cancer is an exceptional hereditary phenomenon and results from inherent mutations in critical genes like a unique case of hereditary breast-ovarian cancer syndrome (HBOC) reported in Combined Military Hospital, Lahore, Pakistan. It was marked by pathogenic variants in RAD51D, PALB2, CHEK1, and TP53 genes. Remarkably, the patient exhibited an outstanding response to the chemotherapy agents, Carboplatin and Paclitaxel. This dynamic treatment not only led to nearly complete remission of high-grade ovarian serous cancer but also triggered regression in grade-2 invasive ductal breast cancer after just a few rounds of chemotherapy. Consequently, what started as palliative care evolved into a curative triumph.
引用
收藏
页码：2184 / 2187
页数：4
相关论文
共 50 条
  • [1] Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer
    De Placido, S
    Tramontana, S
    Ferrari, E
    De Matteis, A
    Lauria, R
    Perrone, F
    Bianco, AR
    Gallo, C
    Ricchi, P
    De Placido, G
    Pignata, S
    ANTICANCER RESEARCH, 2000, 20 (5C) : 4023 - 4029
  • [2] Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
    Reiko Yoshida
    Breast Cancer, 2021, 28 : 1167 - 1180
  • [3] Initial Activation Status of the Antioxidant Response Determines Sensitivity to Carboplatin/Paclitaxel Treatment of Ovarian Cancer
    Pons, Daniel G.
    Sastre-Serra, Jorge
    Nadal-Serrano, Mercedes
    Oliver, Aina
    Garcia-Bonafe, Magdalena
    Bover, Isabel
    Roca, Pilar
    Oliver, Jordi
    ANTICANCER RESEARCH, 2012, 32 (11) : 4723 - 4728
  • [4] Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
    Yoshida, Reiko
    BREAST CANCER, 2021, 28 (06) : 1167 - 1180
  • [5] Treatment of advanced ovarian cancer with carboplatin and paclitaxel in a patient undergoing hemodialysis: Case report and literature review
    Yang, Qing
    Han, Enhong
    Xu, Shanshan
    Xu, Yongxing
    Gao, Jianjun
    HEMODIALYSIS INTERNATIONAL, 2022, 26 (03) : E31 - E36
  • [6] An Overview of Hereditary Breast and Ovarian Cancer Syndrome
    Smith, Edith Caroline
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2012, 57 (06) : 577 - 584
  • [7] Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
    Tan, Xiangbin
    Zou, Shuangyou
    Chen, Hui
    Chen, Dachao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
  • [8] Pharmacokinetic analysis of paclitaxel and carboplatin in a patient with advanced ovarian cancer during hemodialysis - case report
    Yokoyama, Y.
    Futagami, M.
    Higuchi, T.
    Mizunuma, H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (04) : 437 - 439
  • [9] Heterogeneous treatment effect of dose-dense paclitaxel plus carboplatin therapy for advanced ovarian cancer
    Taguchi, Ayumi
    Kato, Kosuke
    Furusawa, Akiko
    Hara, Konan
    Sone, Kenbun
    Yamada, Kyosuke
    Kajiyama, Hiroaki
    Shimada, Muneaki
    Okamoto, Aikou
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (06) : 1068 - 1077
  • [10] Gallbladder Cancer Showing a Great Response to Paclitaxel Plus Carboplatin Chemotherapy: A Case Report
    Inoue, Yoshihiro
    Ota, Masato
    Fujii, Kensuke
    Matsuda, Junna
    Kawaguchi, Nao
    Imai, Yoshiro
    Shimizu, Tetsunosuke
    Asakuma, Mitsuhiro
    Takeshita, Atsushi
    Hirokawa, Fumitoshi
    Hayashi, Michihiro
    Uchiyama, Kazuhisa
    INTERNATIONAL SURGERY, 2018, 103 (1-2) : 66 - 71
12345